Global cancer statistics among older adults in 2024 with projections to 2050: a multi-source population-based analysis.
9 affiliations
- 1Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
- 2Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
- 3Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.
- 4Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
- 5Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashi, 120 Yingbin Road, Kashgar Prefecture, Xinjiang, 844000, China.
- 6Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, 410005, China. [email protected].
- 7Department of Hepatobiliary, Pancreatic and Splenic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. [email protected].
- 8Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. [email protected].
- 9Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. [email protected].
Abstract
Background
Cancer is the second leading cause of death worldwide and disproportionately affects older adults. As population ageing accelerates, the global cancer burden among older adults continues to increase. This study systematically evaluated the latest global cancer burden and its epidemiological characteristics among older adults.Methods
Data on the incidence and mortality of 33 malignancies, excluding non-melanoma skin cancer, among adults aged 65 + were extracted from the Global Cancer Observatory (GLOBOCAN) 2024 and Global Burden of Disease Study (GBD) 2023 databases and stratified by age, sex, region, and Human Development Index (HDI). Age-standardized incidence and mortality rates (ASIR and ASMR) were calculated. Annual percentage changes (APC) were used to characterize temporal trends. Decomposition analysis was performed to quantify the contributions of population growth, population aging, and epidemiological changes. Demographic projection methods and generalized additive model (GAM) were applied to forecast the cancer burden through 2050.Results
In 2024, there were 9,966,392 new cancer cases and 6,001,290 cancer deaths among older adults worldwide, accounting for 51.11% and 61.84%, respectively, of all-age totals. Lung, colorectal, stomach, liver, and prostate cancers were leading causes of death. Incidence and mortality were higher in men and increased with age. The Western Pacific Region had the largest burden, whereas Europe Region had the highest ASIR. ASIR correlated positively with HDI (rs = 0.771), while mortality-to-incidence ratio (MIR) correlated negatively (rs = -0.825). From 2000 to 2023, ASIR and ASMR declined, although burden increased, primarily driven by population growth; pancreatic cancer exhibited the most rapid increase. Tobacco use remained the leading risk factor for mortality, while metabolic risks rose in importance. Under a demographic scenario assuming constant 2024 age-specific rates and changes only in population size and age structure, new cancer cases and deaths among older adults are projected to reach approximately 19.8 million and 12.5 million by 2050, roughly double the 2024 figures, with the largest increase in the Eastern Mediterranean region.Conclusion
Cancer burden in older adults is substantial, varying by sex, age, region, and development level. Precision prevention and control are urgently needed, particularly in low- and middle-income regions. REGISTRY AND THE REGISTRATION NO.Of the study/trial
N/A.
Related
- Gastric cancer burden from 1990 to 2021, Joinpoint analysis, projections to 2036, and health inequality assessment : Findings from the Global Burden of Disease study 2021
- Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer
- The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections
- Long-term trends, age-period-cohort patterns, and future projections of incident stroke with comorbid hypertension and diabetes among older adults in Shenzhen, China: a population-based surveillance study.
- Global, Regional, and National Burden of Ovarian Cancer Among Women of Reproductive Age, 1990–2021, with Projections to 2040: A Global Burden of Disease Study 2021 Analysis
BibTeX
@article{jiang2026global,
title = {{Global cancer statistics among older adults in 2024 with projections to 2050: a multi-source population-based analysis.}},
author = {Jiahao Jiang and Maoqi Wang and Zhijun Chen and Junkai Guo and Xuhong Xu and Meng Wang and Ruikai Li and Abudouxikuer Abudoumijiti and Salam Mijit and Kahaer Tuerxun and Zhiqin Xie and Jizong Lin and Qibin Tang},
journal = {Journal of hematology \& oncology},
year = {2026},
month = oct,
doi = {10.1186/s13045-026-01862-y},
url = {https://europepmc.org/article/MED/42958334},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Global cancer statistics among older adults in 2024 with projections to 2050: a multi-source population-based analysis.
AU - Jiahao Jiang
AU - Maoqi Wang
AU - Zhijun Chen
AU - Junkai Guo
AU - Xuhong Xu
AU - Meng Wang
AU - Ruikai Li
AU - Abudouxikuer Abudoumijiti
AU - Salam Mijit
AU - Kahaer Tuerxun
AU - Zhiqin Xie
AU - Jizong Lin
AU - Qibin Tang
PY - 2026
DA - 2026/10/28
JO - Journal of hematology & oncology
DO - 10.1186/s13045-026-01862-y
UR - https://europepmc.org/article/MED/42958334
AB - Background Cancer is the second leading cause of death worldwide and disproportionately affects older adults. As population ageing accelerates, the global cancer burden among older adults continues to increase. This study systematically evaluated the latest global cancer burden and its epidemiological characteristics among older adults.Methods Data on the incidence and mortality of 33 malignancies, excluding non-melanoma skin cancer, among adults aged 65 + were extracted from the Global Cancer Observatory (GLOBOCAN) 2024 and Global Burden of Disease Study (GBD) 2023 databases and stratified by age, sex, region, and Human Development Index (HDI). Age-standardized incidence and mortality rates (ASIR and ASMR) were calculated. Annual percentage changes (APC) were used to characterize temporal trends. Decomposition analysis was performed to quantify the contributions of population growth, population aging, and epidemiological changes. Demographic projection methods and generalized additive model (GAM) were applied to forecast the cancer burden through 2050.Results In 2024, there were 9,966,392 new cancer cases and 6,001,290 cancer deaths among older adults worldwide, accounting for 51.11% and 61.84%, respectively, of all-age totals. Lung, colorectal, stomach, liver, and prostate cancers were leading causes of death. Incidence and mortality were higher in men and increased with age. The Western Pacific Region had the largest burden, whereas Europe Region had the highest ASIR. ASIR correlated positively with HDI (rs = 0.771), while mortality-to-incidence ratio (MIR) correlated negatively (rs = -0.825). From 2000 to 2023, ASIR and ASMR declined, although burden increased, primarily driven by population growth; pancreatic cancer exhibited the most rapid increase. Tobacco use remained the leading risk factor for mortality, while metabolic risks rose in importance. Under a demographic scenario assuming constant 2024 age-specific rates and changes only in population size and age structure, new cancer cases and deaths among older adults are projected to reach approximately 19.8 million and 12.5 million by 2050, roughly double the 2024 figures, with the largest increase in the Eastern Mediterranean region.Conclusion Cancer burden in older adults is substantial, varying by sex, age, region, and development level. Precision prevention and control are urgently needed, particularly in low- and middle-income regions. REGISTRY AND THE REGISTRATION NO.Of the study/trial N/A.
SN - 1756-8722
ER -